POSCO Holdings Up Over 7%, On Track for Largest Percent Increase Since April 2020 — Data Talk
POSCO Holdings Inc. Sponsored ADR ( PKX ) is currently at $70.54, up $4.83 or 7.35%
--Would be highest close since Sept. 27, 2021, when it closed at $72.79
--On pace for largest percent increase since April 13, 2020, when it rose 10.72%
--Currently up seven of the past eight days
--Currently up five consecutive days; up 14.05% over this period
--Longest winning streak since Nov. 14, 2022, when it rose for eight straight trading days
--Best five day stretch since the five days ending Nov. 14, 2022, when it rose 14.2%
--Up 15.66% month-to-date; on pace for best month since Nov. 2022, when it rose 31.54%
--Up 29.5% year-to-date
--Down 63.99% from its all-time closing high of $195.89 on Oct. 2, 2007
--Up 18.1% from 52 weeks ago (April 1, 2022), when it closed at $59.73
--Would be a new 52-week closing high
--Up 92.68% from its 52-week closing low of $36.61 on Sept. 30, 2022
--Traded as high as $70.56; highest intraday level since Sept. 28, 2021, when it hit $71.06
--Up 7.38% at today's intraday high; largest intraday percent increase since March 3, 2021, when it rose as much as 7.75%
All data as of 11:33:00 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 31, 2023 11:50 ET (15:50 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise